![Christopher Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd. from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd. from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Precedenti posizioni note di Christopher Parker
| Società | Posizione | Fine |
|---|---|---|
| ANTEOTECH LIMITED | Amministratore Delegato | 01/12/2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Corporate Officer/Principal | 01/07/2017 |
Formazione di Christopher Parker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnteoTech Ltd.
 AnteoTech Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes proprietary surface coatings for health care & life sciences | Health Technology |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Health Technology |
